Steris Plc Stock Intrinsic Value – STERIS PLC Reports First Quarter Earnings Results for FY2024 Ending June 30 2023

🌥️Earnings Overview

On August 1st 2023, STERIS PLC ($NYSE:STE) reported its earnings results for the first quarter of FY2024 ending June 30th 2023. The company’s total revenue experienced an increase of 11.1% year-on-year, amounting to USD 1284.5 million, while its net income rose 11.0% to USD 123.6 million for the same period.

Price History

The stock opened at $223.8 and closed at $224.0, down by 0.7% from its prior closing price of 225.6. The company is optimistic about its future prospects and is confident of continuing to generate strong returns for investors. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Steris Plc. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Steris Plc. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Steris Plc. More…

Key Ratios Snapshot

Some of the financial key ratios for Steris Plc are shown below. More…

Analysis – Steris Plc Stock Intrinsic Value

At GoodWhale, we conducted an analysis of STERIS PLC‘s fundamentals and were able to estimate a fair price of $236.4 for their stock price using our proprietary Valuation Line. Currently, the stock is traded at a price of $224.0, meaning it is undervalued by 5.2%. This could be a great opportunity for investors to add STERIS PLC to their portfolios at a discounted rate given its current market price. More…

Peers

The company’s main competitors are Fonar Corp, Stryker Corp, and Dynatronics Corp.

– Fonar Corp ($NASDAQ:FONR)

Fonar Corporation is a holding company, which engages in the design, manufacture, sale, and service of magnetic resonance imaging (MRI) scanners. It operates through the following segments: Upright Multi-Position MRI; Stand-Up MRI; and Recurring Revenue. The Upright Multi-Position MRI segment designs, manufactures, and sells Upright Multi-Position MRI scanners. The Stand-Up MRI segment designs, manufactures, sells, and services Stand-Up MRI scanners. The Recurring Revenue segment provides service contracts, technical support, and parts sales. The company was founded by Stanley C. Krulick in 1978 and is headquartered in Melville, NY.

– Stryker Corp ($NYSE:SYK)

Stryker Corporation is one of the world’s leading medical technology companies. It offers a wide range of medical devices and services, including orthopedics, neurotechnology, and medical imaging. It has more than 87,000 employees worldwide.

– Dynatronics Corp ($NASDAQ:DYNT)

Dynatronics Corp is a medical device company that manufactures and markets physical therapy products and solutions. The company’s products are used by physical therapists, occupational therapists, athletic trainers, and other healthcare professionals. Dynatronics Corp has a market cap of 8.73M as of 2022, a Return on Equity of -10.7%. The company’s products are sold in the United States and internationally.

Summary

STERIS PLC‘s Q1 FY2024 earnings demonstrate the company’s strong performance, with total revenue increasing 11.1% and net income rising 11.0% year-over-year. STERIS PLC is a great investment opportunity for investors looking for a safe and reliable return, with a positive outlook for growth in the coming quarters. The company is well-positioned to capitalize on its recent successes, as its products and services continue to be well-received in the market.

Additionally, the company has strong financials that will help it to stay afloat during tough economic times. Consequently, investors should consider taking advantage of STERIS PLC’s good performance and investing in its future growth.